Inventor
JO DAEWOONG
KR19 patents
⚠️ This page may combine multiple inventors who share the name “JO DAEWOONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELLIVERY THERAPEUTICS INC
14 patentsUS10781241B2Sep 22, 2020
Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof
CELLIVERY THERAPEUTICS INC3 citations83
US10385103B2Aug 20, 2019
Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
CELLIVERY THERAPEUTICS INC7 citations83
US10975132B2Apr 13, 2021
Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
CELLIVERY THERAPEUTICS INC2 citations72
US10961292B2Mar 30, 2021
Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
CELLIVERY THERAPEUTICS INC2 citations72
US10787492B2Sep 29, 2020
Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof
CELLIVERY THERAPEUTICS INC2 citations72
US10689424B2Jun 23, 2020
Cell-permeable (CP)-Δ SOCS3 recombinant protein and uses thereof
CELLIVERY THERAPEUTICS INC2 citations72
US10669531B2Jun 2, 2020
Cell-permeable Cre (iCP-Cre) recombinant protein and use thereof
CELLIVERY THERAPEUTICS INC2 citations72
US10662419B2May 26, 2020
Cell-permeable (ICP) parkin recombinant protein and use thereof
CELLIVERY THERAPEUTICS INC2 citations72
US10508265B2Dec 17, 2019
Cell-permeable reprogramming factor (iCP-RF) recombinant protein and use thereof
CELLIVERY THERAPEUTICS INC3 citations72
US10323072B2Jun 18, 2019
Cell-permeable (CP)-Δ SOCS3 recombinant protein and uses thereof
CELLIVERY THERAPEUTICS INC2 citations72
US10323063B2Jun 18, 2019
Advanced macromolecule transduction domain (aMTD) sequences for improvement of cell-permeability, polynucleotides encoding the same, method to identify the unique features of aMTDs comprising the same, method to develop the aMTD sequences comprising the same
CELLIVERY THERAPEUTICS INC3 citations72
US11319546B2May 3, 2022
Cell-permeable (CP)-Cas9 recombinant protein and uses thereof
CELLIVERY THERAPEUTICS INC0 citations62
US11279743B2Mar 22, 2022
Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof
CELLIVERY THERAPEUTICS INC0 citations62
US10774123B2Sep 15, 2020
Cell-permeable bone morphogenetic protein (CP-BMP) recombinant protein and use thereof
CELLIVERY THERAPEUTICS INC0 citations51
JO DAEWOONG
4 patentsUS8450279B2May 28, 2013
Cell permeable Nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
JO DAEWOONG4 citations54
US8470971B2Jun 25, 2013
Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient
JO DAEWOONG0 citations46
US8586544B2Nov 19, 2013
Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component
JO DAEWOONG0 citations45
US8445443B2May 21, 2013
Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the same
JO DAEWOONG1 citations42